INGR Ingredion Incorporated

Cooke & Bieler, an investment management firm, released its second-quarter investor letter for “Mid Cap Value Equity Strategy.” The letter can be downloaded here. U.S. equities rallied significantly in Q2, driven by shifting geopolitical risks and strong investor appetite for high-beta stocks, particularly in the tech sector, contributing to the S&P 500® and Nasdaq’s best […]

Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investor’s dilemma: bargain opportunity or value trap?

Ingredion's margins remain under pressure as surging tapioca costs outpace pricing despite resilient specialty demand and strong volumes.

Ingredion shares closed at US$97.91 after a mixed few years for holders, and the bigger question now is whether that price lines up with the cash the business is expected to generate over time. Over the past 5 years the stock has returned 25.9%. This puts real weight on whether that gain is grounded in the company’s underlying cash flows or mainly in changing market sentiment. The planned US$3.6b purchase of Tate & Lyle can reshape Ingredion’s mix toward texture and health focused...

Rate hikes, stubborn inflation and policy headlines are reshaping the income corner of the market, and that mix is putting high-quality dividend-paying stocks in the spotlight for investors who care about both cash flow and resilience. Miss the right opportunities and you risk watching others collect steady payouts while you sit on the sidelines. This article walks through three stocks from our screener that appear positively exposed to these shifts at the moment. The three individual stocks...

Dividend increase puts Ingredion’s cash returns in focus Ingredion (INGR) has approved a quarterly dividend of $0.83 per share, payable on October 20, 2026. This marks the twelfth straight third quarter with a higher payout. Regular raises like this tend to draw attention from income focused investors, who track both the absolute cash yield and how comfortably those distributions sit against earnings, cash flow, and recent share performance. Ingredion’s dividend move lands after a softer...

Ingredion Incorporated (NYSE:INGR) increased its quarterly dividend to $0.83 per share, up from $0.82, marking the 12th consecutive year in which the company has raised its quarterly dividend in the third quarter. The new payout implies an annualized dividend of $3.32 per share. At around $97–$104 per share, the annualized dividend implies a yield of […]

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

The acquisition is set to position Ingredion as the "go-to provider for texture and healthful solutions" within the food and beverage industries, according to its CEO.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Ingredion's LATAM sales rise in Q2, but softer Mexico demand and currency effects hurt margins, with 2026 operating income expected to decline.

Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. On the other hand, they usually underperform during bull runs, and this paradigm has rung true over the past six months as the sector’s -5.1% decline paled in comparison to the S&P 500’s 11.7% gain.

Download the Complete Report Here Beyond Oil Ltd. (BOIL/BEOLF) Record Revenue and U.S. Direct-Sales Buildout Support Scaling Phase; Enterprise Rollouts and Margin Recovery Shape 2H Setup Key Takeaways: 2Q26 revenue of $1.40 million increased 28% y/y and 11% sequentially, lifting first-half revenue 26% to $2.65 million. S. commercial infrastructure is increasingly established, with 100+ validated […] The post Beyond Oil: Record Revenue & U.S. Direct-Sales Expansion Fuel Scaling Phase – Quarterly

Ingredion’s Q2 results were met favorably by the market, driven by ongoing momentum in its Texture & Healthful Solutions segment. Management highlighted nine consecutive quarters of volume growth in this area, supported by customer demand for clean-label, health-forward ingredients and new product launches. Operational challenges at the Argo facility and softer demand in Food & Industrial Ingredients U.S./Canada tempered results, but sequential production improvements at Argo and robust executio

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how ingredients, flavors & fragrances stocks fared in Q2, starting with Ingredion (NYSE:INGR).

Tate & Lyle acquisition and Argo recovery amid tapioca cost pressures.

AgTech and food innovation reshape agriculture and nutrition, putting ADM, DAR and BG firmly in focus.

What the fresh guidance means for Ingredion stock Ingredion (INGR) has put updated numbers on the table. The company reaffirmed its full year 2026 earnings guidance and set expectations for modest net sales growth in the third quarter. This fresh guidance arrives alongside second quarter 2026 results, a completed buyback tranche, and progress on the proposed Tate & Lyle acquisition. Together, these developments give investors several new data points to weigh. See our latest analysis for...

ADM is benefiting from stronger biofuels economics and crushing margins while capacity investments support additional growth.

Archer Daniels raises its 2026 earnings outlook after a strong Q2, as crushing, ethanol and Nutrition gains fuel profit growth while execution risks remain.

Ingredion beats Q2 estimates as 7% Texture & Healthful Solutions volume growth and FX gains offset Argo issues and higher costs.

Ingredion (NYSE:INGR) reported second-quarter 2026 results that were in line with its expectations, as continued growth in Texture & Healthful Solutions offset operational and macroeconomic pressures in other parts of the portfolio. Second-quarter net sales increased 1% year over year to $1.85

Moby summary of Ingredion Incorporated's Q2 2026 earnings call

Texture and Healthful Solutions delivers record performance while Argo facility recovery and Tate & Lyle acquisition shape the company's outlook.

Ingredion (INGR) delivered earnings and revenue surprises of +3.30% and +2.32%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Food ingredient solutions provider Ingredion (NYSE:INGR) reported Q2 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.85 billion. Its non-GAAP profit of $2.82 per share was 3.6% above analysts’ consensus estimates.

Ingredion's proposed $5 billion Tate & Lyle deal could expand its specialty platform and global reach, but approvals and integration risks remain.

Ingredion's cheap valuation and growing specialty business support the bull case, but Argo execution risks and weaker guidance argue for patience.

Food ingredient solutions provider Ingredion (NYSE:INGR) will be reporting earnings this Tuesday before market open. Here’s what to expect.

The full-year range went up, but one of four segments was guided lower, and most of the second half now rests on the stretch that management flags for the most uncertainty.

Kraft Heinz (KHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tate & Lyle’s updated fair value estimate has shifted from £4.84 to £5.35, placing current analyst work more clearly in the mid £5 range that readers have seen referenced around recent price targets. That adjustment sits alongside commentary highlighting how the Ingredion offer and closely grouped targets between £5.47 and £5.95 are reshaping the risk and reward story, with several analysts moving to more neutral ratings. Keep reading to see how these numbers fit together and how to track the...